Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors.

Lim JU, Tao D, Selvadurai PN, Dumbrava EE, Naing A, Champiat S, Mirallas O, Kang L, Le H, Tsimberidou AM, Ahnert JR, Piha-Paul SA, Fu S, Yap TA, Tang TY, Meric-Bernstam F, Sheshadri A, Hong DS

Open source

DOI: 10.3389/fimmu.2026.1848516
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1848516,
  title = {Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors.},
  author = {Lim JU and Tao D and Selvadurai PN and Dumbrava EE and Naing A and Champiat S and Mirallas O and Kang L and Le H and Tsimberidou AM and Ahnert JR and Piha-Paul SA and Fu S and Yap TA and Tang TY and Meric-Bernstam F and Sheshadri A and Hong DS},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1848516},
  url = {https://doi.org/10.3389/fimmu.2026.1848516}
}

RIS

TY  - JOUR
TI  - Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors.
AU  - Lim JU
AU  - Tao D
AU  - Selvadurai PN
AU  - Dumbrava EE
AU  - Naing A
AU  - Champiat S
AU  - Mirallas O
AU  - Kang L
AU  - Le H
AU  - Tsimberidou AM
AU  - Ahnert JR
AU  - Piha-Paul SA
AU  - Fu S
AU  - Yap TA
AU  - Tang TY
AU  - Meric-Bernstam F
AU  - Sheshadri A
AU  - Hong DS
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1848516
UR  - https://doi.org/10.3389/fimmu.2026.1848516
ER  -

APA

JU, L., D, T., PN, S., EE, D., A, N., S, C., O, M., L, K., H, L., AM, T., JR, A., SA, P., S, F., TA, Y., TY, T., F, M., A, S., & DS, H. (2026). Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1848516

Source records

pubmed · retrieved 2026-09-26T00:36:07.803Z